Targeting Toll-like receptor 4 with CLI-095 (TAK-242) enhances the antimetastatic effect of the estrogen receptor antagonist fulvestrant on non-small cell lung cancer
Frank S. Fan(Temasek Life Sciences Laboratory), Bo Ai(Chinese Academy of Tropical Agricultural Sciences)
Cited by 9